Pharmaceuticals · 2023 · 49 citations · 73 references
MedicineMedicinal ChemistryPharmacologyBehavioral PharmacologyNeuropharmacologyPsychopharmacologyAnxiolytic PharmacologyAnxiolytic TherapyGabaergic NeurochemistryGabaergic PharmacologyGabaergic SignalingStructure-activity Relationship AnalysisAllosteric Modulator BindingAnxiolytic ActionGaba AgonistsGaba-a Receptor PharmacologyMolecular Docking AnalysisOpen-field TestPharmacodynamics Of AnxiolyticsPositive Allosteric Modulation
Numerous previous studies reported that ferulic acid exerts anxiolytic activity. However, the mechanisms have yet to be elucidated. The current study aimed to investigate the anxiolytic effect of trans-ferulic acid (TFA), a stereoisomer of ferulic acid, and evaluated its underlying mechanism using in vivo and computational studies. For this, different experimental doses of TFA (25, 50, and 75 mg/kg) were administered orally to Swiss albino mice, and various behavioral methods of open field, hole board, swing box, and light–dark tests were carried out. Diazepam (DZP), a positive allosteric modulator of the GABAA receptor, was employed as a positive control at a dose of 2 mg/kg, and distilled water served as a vehicle. Additionally, molecular docking was performed to estimate the binding affinities of the TFA and DZP toward the GABAA receptor subunits of α2 and α3, which are associated with the anxiolytic effect; visualizations of the ligand-receptor interaction were carried out using various computational tools. Our findings indicate that TFA dose-dependently reduces the locomotor activity of the animals in comparison with the controls, calming their behaviors. In addition, TFA exerted the highest binding affinity (−5.8 kcal/mol) to the α2 subunit of the GABAA receptor by forming several hydrogen and hydrophobic bonds. Taken together, our findings suggest that TFA exerts a similar effect to DZP, and the compound exerts moderate anxiolytic activity through the GABAergic interaction pathway. We suggest further clinical studies to develop TFA as a reliable anxiolytic agent.
73
PDBsum: Structural summaries of PDB entries
Roman A. Laskowski, Jagoda Jabłońska, Lukáš Pravda et al. · Protein Science · 2017 · 1.8K citations · Full text
Protein structure homology modeling using SWISS-MODEL workspace
Lorenza Bordoli, Florian Kiefer, Konstantin Arnold et al. · Nature Protocols · 2008 · 1.3K citations
Molecular and Neuronal Substrate for the Selective Attenuation of Anxiety
Karin Löw, Florence Crestani, Ruth Keist et al. · Science · 2000 · 941 citations
Medicine, Neuroscience, Pharmacology +17